T akotsubo syndrome (TTS) is an acute heart failure syndrome that predominantly affects post-menopausal women. It is characterized by substantial morbidity and mortality, which equal those of acute coronary syndromes (ACS) and are still underappreciated (1). TTS and ACS share many clinical features on admission, and an estimated 1% to 2% of all patients with suspected ACS are finally diagnosed with TTS (2). However, knowledge of diagnostic criteria is often incomplete (e.g., regarding the possible coexistence of coronary artery disease [CAD]) and atypical forms are frequently not recognized, both of which contribute to the low reported incidence of TTS. In early years, the disease was considered to be typically preceded by an emotional trigger; however, recent studies demonstrate that physical triggers are equally important and that TTS may frequently occur without an evident trigger (1,3). A hallmark of TTS patients is the predominant prevalence of neuropsychiatric comorbidities (1,4,5).
T akotsubo syndrome (TTS) is an acute heart failure syndrome that predominantly affects post-menopausal women. It is characterized by substantial morbidity and mortality, which equal those of acute coronary syndromes (ACS) and are still underappreciated (1) . TTS and ACS share many clinical features on admission, and an estimated 1% to 2% of all patients with suspected ACS are finally diagnosed with TTS (2) . However, knowledge of diagnostic criteria is often incomplete (e.g., regarding the possible coexistence of coronary artery disease [CAD] ) and atypical forms are frequently not recognized, both of which contribute to the low reported incidence of TTS. In early years, the disease was considered to be typically preceded by an emotional trigger; however, recent studies demonstrate that physical triggers are equally important and that TTS may frequently occur without an evident trigger (1, 3) . A hallmark of TTS patients is the predominant prevalence of neuropsychiatric comorbidities (1, 4, 5) .
However, despite many efforts, the exact pathophysiological mechanism behind TTS remains elusive and primarily relies on assumptions (6) .
In this issue of the Journal, Tornvall et al. (7) report data from 505 TTS patients identified from the SCAAR (Swedish Angiography and Angioplasty Register) from 2009 to 2013. SCAAR data was combined with records from the Swedish national patient registry, the prescribed drug register, and the cause of death registry. The authors conducted a case-control study of TTS patients without coexisting CAD and compared it with 2 control groups. As stated by the authors, 1 had "unstable CAD or STEMI treated with percutaneous coronary intervention" and the other had "chest pain of unknown cause and nonobstructive coronaries," as documented by coronary angiography (7). The main finding was that adjusted long-term mortality of TTS is comparable to that of ACS but is worse than that of control subjects with chest pain but without CAD. The authors conclude that TTS is a serious condition and affects long-term prognosis. Their findings are important, as it is still widely but erroneously assumed that prognosis of TTS is universally benign.
However, previous studies have shown that inhospital outcome of TTS and ACS is comparable (1), and 2 studies on long-term prognosis compared with a reference cohort showed conflicting results (3, 8) . The study of Tornvall et al. (7) is the first that investigates long-term outcome of TTS compared with ACS.
The present study follows an important and potentially insightful aim: to make use of national (governmental) registries for assessing mortality and risk factors of an understudied and rather rare disease. Scandinavian countries host high-quality databases on morbidity and mortality, which have already provided valuable information on other entities (9) .
However, data quality of registries generally depends on accurate entries and maintenance. In the present study, many parameters were assessed on the basis of International Classification of Diseases-10th Revision codes, and verification of source data integrity was probably not possible. As such, conclusions need to be drawn with great caution.
Numerous differences in baseline characteristics between groups were noted, which corroborates data from others (1,10,11). In general, TTS can be detected as a "primary" or as a "bystander" disease in patients authors have reported that they have no relationships relevant to the contents of this paper to disclose. study, we could demonstrate a high prevalence of neurological and psychiatric disease in TTS patients, which outnumbered that of ACS patients (1). The present study found a much lower prevalence (about one-third of our numbers). As also stated by the authors, the value of registries critically depends on careful maintenance, and thus, data obtained from registries may significantly differ between studies.
Another ongoing debate relates to beta-blockers and beta-agonists. Although beta-blockers are often essential in the acute phase and might be life-saving Each puzzle piece represents a feature of Takotsubo syndrome (TTS), categorized by 4 colors: clinical feature (yellow), pathogenesis (blue), treatment and outcome (red), and predisposing factors (green). Some may occur in 2 categories, e.g., triggering factors are a clinical characteristic but probably also play a mechanistic role.
Depending on the level of evidence, the puzzle pieces are either integrated and attached to the heart and/or brain, or did not find their final place yet. As genetics and long-term treatment are definitely central issues in TTS development and management without reasonable evidence from studies, those pieces are single cornerstones.
With the study by Tornvall et al. (7), the piece "long-term treatment" has been moved closer to integration. CAD ¼ coronary artery disease; Cath ¼ catheterization;
LV ¼ left ventricular; LVOTO ¼ left ventricular outflow tract obstruction; MRI ¼ magnetic resonance imaging; PI3K-AKT ¼ phosphoinositide-3-kinase-AKT.
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